A PYMNTS Company

US: DuPont merger Senate hearings to focus on antitrust concerns

By  |  September 19, 2016

Antitrust experts differ on what to expect when a DuPont executive along with other agriculture leaders testify Tuesday morning before the US Senate.

On the other hand, the Senate has no authority to block the proposed $130 billion merger between DuPont and The Dow Chemical, creating the United States’ largest agriculture market player.

“This is theater,” said Roger Dennis, dean of Drexel University’s law school and a former U.S. Department of Justice antitrust attorney. “It will be fascinating to see how the senators use the hearing and the questions they ask, but nothing of substance comes out of these events.”

But Salil Mehra, an antitrust professor at Temple University, said testimony from agriculture trade groups could raise concerns at the hearing that may factor into the Department of Justice’s review of the Dow and DuPont merger.

“There could be commentary from farmers or customers that could play into the normal procedure of the merger review,” he said.

Full Content: Delaware Online

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.